Characteristics of Nausea Reported by HIV-Infected Patients Initiating Combination Antiretroviral Regimens

Nancy R. Reynolds and Judith L. Neidig
Additional contact information
Judith L. Neidig: Ohio State University

Clinical Nursing Research, 2002, vol. 11, issue 1, 71-88

Abstract: Reliable data on the incidence and severity of nausea accompanying combination antiretroviral therapies is lacking. Aprospective time series design was used to assess the rate, severity, and distress of nausea in a cohort of 75 HIV-positive patients who were beginning or changing a combination of two or more antiretroviral medications. Data were collected via telephone at weekly intervals for 12 weeks. The rate of nausea across regimens was greatest at Week 1 (39%) and declined progressively over time. By Week 12, the rate of nausea was only 5%. Severity of nausea was ranked as moderate or severe by a substantial proportion of patients through Week 10; however, nausea severity and distress were also found to diminish over time. The nausea associated with combination antiretroviral therapy is quite common and may adversely affect medication adherence. Findings indicate that clinicians should consider initiating interventions for management of antiretroviral-related nausea at baseline.

Date: 2002
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://journals.sagepub.com/doi/10.1177/105477380201100106 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:sae:clnure:v:11:y:2002:i:1:p:71-88

DOI: 10.1177/105477380201100106

Access Statistics for this article

More articles in Clinical Nursing Research
Bibliographic data for series maintained by SAGE Publications ().